Cooper Companies Beheer

Beheer criteriumcontroles 3/4

De CEO Cooper Companies is Al White, benoemd in May2018, heeft een ambtstermijn van 6.5 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 13.49M, bestaande uit 7.8% salaris en 92.2% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.083% van de aandelen van het bedrijf, ter waarde € 15.68M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 6.8 jaar en 5.3 jaar.

Belangrijke informatie

Al White

Algemeen directeur

US$13.5m

Totale compensatie

Percentage CEO-salaris	7.8%
Dienstverband CEO	6.5yrs
Eigendom CEO	0.08%
Management gemiddelde ambtstermijn	6.8yrs
Gemiddelde ambtstermijn bestuur	5.3yrs

Recente managementupdates

Recent updates

Analyse CEO-vergoeding

Hoe is Al White's beloning veranderd ten opzichte van Cooper Companies's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Jul 31 2024	n/a	n/a	US$359m
Apr 30 2024	n/a	n/a	US$340m
Jan 31 2024	n/a	n/a	US$291m
Oct 31 2023	US$13m	US$1m	US$294m
Jul 31 2023	n/a	n/a	US$275m
Apr 30 2023	n/a	n/a	US$288m
Jan 31 2023	n/a	n/a	US$375m
Oct 31 2022	US$12m	US$925k	US$386m
Jul 31 2022	n/a	n/a	US$431m
Apr 30 2022	n/a	n/a	US$948m
Jan 31 2022	n/a	n/a	US$939m
Oct 31 2021	US$11m	US$925k	US$3b
Jul 31 2021	n/a	n/a	US$3b
Apr 30 2021	n/a	n/a	US$2b
Jan 31 2021	n/a	n/a	US$2b
Oct 31 2020	US$10m	US$925k	US$238m
Jul 31 2020	n/a	n/a	US$278m
Apr 30 2020	n/a	n/a	US$343m
Jan 31 2020	n/a	n/a	US$454m
Oct 31 2019	US$8m	US$925k	US$467m
Jul 31 2019	n/a	n/a	US$446m
Apr 30 2019	n/a	n/a	US$427m
Jan 31 2019	n/a	n/a	US$366m
Oct 31 2018	US$6m	US$689k	US$140m

Compensatie versus markt: De totale vergoeding ($USD 13.49M ) Al } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de German markt ($USD 4.90M ).

Compensatie versus inkomsten: De vergoeding van Al is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.

CEO

Al White (54 yo)

6.5yrs

Tenure

US$13,490,923

Compensatie

Mr. Albert G. White, III, also known as Al, serves as Independent Director of Evolus, Inc. since July 1, 2024. He has been President and Chief Executive Officer of The Cooper Companies, Inc. since May 1, 2...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Albert White	President	6.5yrs	US$13.49m	0.083% € 15.7m
Brian Andrews	Executive VP	11.8yrs	US$3.47m	0.0080% € 1.5m
Daniel McBride	Executive VP & COO	11yrs	US$4.38m	0.070% € 13.2m
Holly Sheffield	President of CooperSurgical	4.3yrs	US$3.22m	0.012% € 2.3m
Gerard Warner	President of CooperVision	2.8yrs	US$2.78m	0.0026% € 489.3k
Agostino Ricupati	Senior VP & Chief Accounting Officer	7.1yrs	US$1.77m	0.0024% € 457.2k
Kim Duncan	Vice President of Investor Relations & Risk Management	10yrs	geen gegevens	geen gegevens
Nicholas Khadder	General Counsel & Corporate Secretary	2.3yrs	geen gegevens	0.00034% € 64.2k

6.8yrs

Gemiddelde duur

54yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van CP60 is doorgewinterd en ervaren (gemiddelde ambtstermijn van 6.8 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Albert White	President	6.7yrs	US$13.49m	0.083% € 15.7m
Robert Weiss	Independent Chairman of the Board	28.8yrs	US$471.82k	0.28% € 52.3m
Teresa Madden	Independent Director	3.9yrs	US$344.94k	0.0048% € 914.3k
William Kozy	Independent Vice Chairman & Lead Director	8.6yrs	US$368.38k	0.014% € 2.7m
Lawrence Kurzius	Independent Director	less than a year	geen gegevens	0.00053% € 100.1k
Cynthia Lucchese	Independent Director	2.1yrs	US$311.61k	0.0025% € 468.5k
Colleen Jay	Independent Director	8.6yrs	US$339.94k	0.013% € 2.5m
Maria Rivas	Independent Director	3.3yrs	US$319.94k	0.0037% € 704.6k

5.3yrs

Gemiddelde duur

65yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van CP60 wordt beschouwd als ervaren (gemiddelde ambtstermijn 5.3 jaar).

Cooper Companies Beheer

Beheer criteriumcontroles 3/4

Belangrijke informatie

Recente managementupdates

The Cooper Companies, Inc. Announces Resignation of Gary S. Petersmeyer from Board of Directors

The Cooper Companies, Inc., Annual General Meeting, Mar 19, 2024

The Cooper Companies, Inc. Announces Retirement of Gary S. Petersmeyer as Director

CooperCompanies Appoints Lawrence E. Kurzius to Board of Directors, Effective December 1, 2023

Senior VP & Chief Accounting Officer recently sold €341k worth of stock

President of CooperVision recently sold €391k worth of stock

Recent updates

The Cooper Companies, Inc. to Report Q4, 2024 Results on Dec 05, 2024

Third quarter 2024 earnings released: EPS: US$0.52 (vs US$0.43 in 3Q 2023)

The Cooper Companies, Inc. Raises Earnings Guidance for the Fourth Quarter and Fiscal Year 2024

The Cooper Companies, Inc. to Report Q3, 2024 Results on Aug 28, 2024

Second quarter 2024 earnings released: EPS: US$0.45 (vs US$0.20 in 2Q 2023)

The Cooper Companies, Inc. Raises Earnings Guidance for the Fiscal Year 2024

The Cooper Companies, Inc. to Report Q2, 2024 Results on May 30, 2024

The Cooper Companies, Inc. Raises its Revenue Guidance for the Fiscal Year 2024

Girard Sharp LLP and Sauder Schelkopf LLC Files Lawsuit Against Coopersurgical, Inc. and the Cooper Companies, Inc

The Cooper Companies, Inc. Announces Resignation of Gary S. Petersmeyer from Board of Directors

Slater Vecchio LLP Files Class Action Lawsuit Against LifeGroup Global LLC, The Cooper Companies Inc, CooperSurgical Inc, and CooperSurgical Canada Inc

Now 20% undervalued

The Cooper Companies, Inc. to Report Q1, 2024 Results on Feb 29, 2024

Now 20% undervalued

The Cooper Companies, Inc., Annual General Meeting, Mar 19, 2024

The Cooper Companies, Inc. Announces Retirement of Gary S. Petersmeyer as Director

Now 20% undervalued after recent price drop

Full year 2023 earnings released: EPS: US$5.91 (vs US$7.83 in FY 2022)

The Cooper Companies, Inc. Provides Revenue Guidance for the Fiscal Year 2024

CooperCompanies Appoints Lawrence E. Kurzius to Board of Directors, Effective December 1, 2023

The Cooper Companies, Inc. to Report Q4, 2023 Results on Dec 07, 2023

The Cooper Companies, Inc. (NasdaqGS:COO) acquired Bakri Postpartum Balloon, Cervical Ripening Balloon, Doppler Blood Flow Monitor portfolio and gynecology surgery markets of Cook Medical Incorporated for $300 million.

The Cooper Companies, Inc. Updates Revenue Guidance for the Year 2023

Third quarter 2023 earnings released: EPS: US$1.71 (vs US$2.00 in 3Q 2022)

Upcoming dividend of US$0.03 per share

The Cooper Companies, Inc. Provides Revenue Guidance for the Year 2023

Second quarter 2023 earnings released: EPS: US$0.80 (vs US$2.57 in 2Q 2022)

Senior VP & Chief Accounting Officer recently sold €341k worth of stock

President of CooperVision recently sold €391k worth of stock

First quarter 2023 earnings released: EPS: US$1.70 (vs US$1.93 in 1Q 2022)

The Cooper Companies, Inc. to Report Q1, 2023 Results on Mar 02, 2023

Upcoming dividend of US$0.03 per share

The Cooper Companies, Inc., Annual General Meeting, Mar 15, 2023

CooperCompanies Declares Cash Dividend, Payable on February 10, 2023

Full year 2022 earnings released: EPS: US$7.76 (vs US$59.85 in FY 2021)

The Cooper Companies, Inc. Initiates Earnings Guidance for the Fiscal Year 2023

The Cooper Companies, Inc. to Report Q4, 2022 Results on Dec 08, 2022

the Cooper Companies, Inc. Appoints Cynthia Lucchese to Board of Directors

Third quarter 2022 earnings released: EPS: US$1.98 (vs US$12.49 in 3Q 2021)

the Cooper Companies, Inc. Updates Revenue Guidance for Fourth Quarter and Full year 2022

the Cooper Companies, Inc. Updates Revenue Guidance for Fourth Quarter and Full Year Year 2022

CooperCompanies Appoints Nicholas Khadder as Its General Counsel and Corporate Secretary

The Cooper Companies, Inc. to Report Q3, 2022 Results on Aug 31, 2022

Upcoming dividend of US$0.03 per share

CooperCompanies Declares Semi-Annual Cash Dividend, Payable on August 11, 2022

The Cooper Companies, Inc. Provides Consolidated Earnings Guidance for the Third Quarter, Fourth Quarter and Full Year of Fiscal 2022

Second quarter 2022 earnings released: EPS: US$2.55 (vs US$2.39 in 2Q 2021)

Independent Director recently sold €113k worth of stock

The Cooper Companies, Inc. Provides Revenue Earnings Guidance for the Fiscal Year 2022

First quarter 2022 earnings: EPS in line with analyst expectations despite revenue beat

The Cooper Companies, Inc. (NYSE:COO) signed a binding letter of intent to acquire Reproductive Health Business of Cook Medical for $880 million.

The Cooper Companies, Inc. to Report Q1, 2022 Results on Mar 03, 2022

Insufficient new directors

Inaugural dividend of US$0.03 per share

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

The Cooper Companies, Inc. Provides Earnings Guidance for the Fiscal Year 2022

Independent Director recently sold €170k worth of stock

Third quarter 2021 earnings released: EPS US$12.37 (vs US$1.12 in 3Q 2020)

The Cooper Companies, Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year of Fiscal 2021

CooperCompanies Announces MiSight® Approval from Chinese National Medical Products Administration

Inaugural dividend of US$0.03 per share

Independent Director recently sold €139k worth of stock

The Cooper Companies, Inc.(NYSE:COO) dropped from Russell 1000 Growth-Defensive Index

Second quarter 2021 earnings released: EPS US$2.36 (vs US$0.23 in 2Q 2020)

the Cooper Companies, Inc. Provides Earnings Guidance for the Fiscal Year 2021

Revenue beats expectations

First quarter 2021 earnings released: EPS US$42.28 (vs US$1.84 in 1Q 2020)

New 90-day high: €323

New 90-day high: €320